There is no specific treatment for achondroplasia other than managing symptoms. Monitoring height, weight and head circumference is recommended during early diagnosis in infants to track growth progress. Is there a cure for achondroplasia?

2023年5月31日 · Achondroplasia is not a condition that requires a cure or treatment. However, some people with achondroplasia may require treatment to help manage complications of the condition.

Today, the U.S. Food and Drug Administration approved Voxzogo (vosoritide) injection to improve growth in children five years of age and older with achondroplasia and open epiphyses (growth...

Treatment for lower extremity misalignment might include surgery to correct the limbs. If a dangerously compressed region of the foramen magnum or spinal column is found, a surgeon can remove bone and ligaments from the problem area to …

The most personalized care for achondroplasia comes from a team of providers from different specialties, selected based on your child’s unique diagnosis, needs and goals. This team works together to create a care plan to manage their achondroplasia and any complications.

How do we treat achondroplasia? Because of the wide range of symptoms, there is no one specific achondroplasia treatment. However, children diagnosed with achondroplasia need to have their height, weight, and head circumference monitored.

Treatments for achondroplasia include pharmacological treatments to increase linear bone growth, surgical interventions (most of which manage ACH-related complications), and rehabilitative therapies to manage neuromusculoskeletal deficits related to achondroplasia.

Treatment options for achondroplasia include managing symptoms to support a normal life span. Caused by genetic mutation, may cause limited range of motion, while intelligence remains normal.

Currently, there is no way to prevent achondroplasia, since most cases result from unexpected new mutations. Treatment addresses symptoms or results of the condition that can affect health and well-being. Vosoritide was the first medication approved by …

Several precision-based therapies have emerged that target the pathogenetic source. Vosoritide, a C-type natriuretic peptide analogue, is the first of these treatments to be approved for use in children with achondroplasia to increase linear growth.